We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+23.39%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$1.47B
AUM Growth
+$375M
Cap. Flow
+$157M
Cap. Flow %
10.72%
Top 10 Hldgs %
58.22%
Holding
55
New
7
Increased
25
Reduced
10
Closed
4

Top Buys

Rank Stock Value
1
PRQR icon
ProQR Therapeutics
PRQR
+$48.9M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$33.2M
3
BMY icon
Bristol-Myers Squibb
BMY
+$28.6M
4
PTCT icon
PTC Therapeutics
PTCT
+$19.9M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$19M

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$62.5M
2
RGNX icon
Regenxbio
RGNX
+$29.7M
3
SAGE
Sage Therapeutics
SAGE
+$15.9M
4
ASMB icon
Assembly Biosciences
ASMB
+$15.5M
5
QURE icon
uniQure
QURE
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 91.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIVN icon
51
PUT
LivaNova
LIVN
$4.16B
– –
-7,900
Closed -$723K
SAGE
52
DELISTED
Sage Therapeutics
SAGE
– –
-165,990
Closed -$15.9M
VTAK icon
53
Catheter Precision
VTAK
$977K
– –
0
– -$487K
KA
54
DELISTED
Kineta, Inc. Common Stock
KA
– –
-2,239
Closed -$1.02M
1 2
3

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

RTW Investments's Q1 2019 Portfolio in Review

As of Q1 2019, RTW Investments held 55 positions worth $1.47B, up 34% from $1.09B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

RTW Investments deployed $157M of net new capital in Q1 2019, opening 7 new positions and adding to 25 existing holdings. Its largest new stake was Wave Life Sciences: 436,777 shares worth $17M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier.

On the sell side, the largest reduction was Arrowhead Research, an estimated $62.5M trimmed.

  • RTW Investments's largest Q1 2019 buy was Wave Life Sciences: 436,777 shares worth $17M.
  • RTW Investments added most to ProQR Therapeutics in Q1 2019, an estimated $48.9M increase.
  • RTW Investments's biggest Q1 2019 reduction was Arrowhead Research, cutting an estimated $62.5M.
  • RTW Investments fully exited Sage Therapeutics in Q1 2019, selling an estimated $15.9M.
  • RTW Investments's ten largest holdings make up 58% of its $1.47B portfolio in Q1 2019.
  • RTW Investments opened 7 new positions and closed 4 in Q1 2019.
  • RTW Investments's portfolio value rose 34% quarter-over-quarter to $1.47B.

Based on RTW Investments's 13F filing for Q1 2019, filed 15 May 2019.